https://www.aidsmap.com/about-hiv/arv-background-information/lenacapavir-sunlenca
Lenacapavir is the first HIV capsid inhibitor. Lenacapavir has been licensed in the United States, European Union and United Kingdom for the treatment of...
lenacapavirsunlencaaidsmap